A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of Centanafadine
Clinical trial NCT07465731 · COMPLETED
Trial details
- NCT number
- NCT07465731
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-27
- Primary completion
- 2023-03-26
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.